The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history
Open accessAbstract
PurposePanel-based genetic testing has identified increasing numbers of patients with pancreatic ductal adenocarcinoma (PDAC) who carry germ-line mutations. However, small sample sizes or number of genes evaluated limit prevalence estimates of these mutations. We estimated prevalence of mutations in PDAC patients with positive family history.MethodsWe sequenced 25 cancer susceptibility genes in lymphocyte DNA from 302 PDAC patients in the Mayo Clinic Biospecimen Resource for Pancreatic Research Registry. Kindreds containing at least two first-degree relatives with PDAC met criteria for familial pancreatic cancer (FPC), while the remaining were familial, but not FPC.ResultsThirty-six patients (12%) carried at least one deleterious mutation in one of 11 genes. Of FPC patients, 25/185 (14%) were carriers, while 11/117 (9%) non-FPC patients with family history were carriers. Deleterious mutations (n) identified in PDAC patients were BRCA2 (11), ATM (8), CDKN2A (4), CHEK2 (4), MUTYH/MYH (3 heterozygotes, not biallelic), BRCA1 (2), and 1 each in BARD1, MSH2, NBN, PALB2, and PMS2. Novel mutations were found in ATM, BARD1, and PMS2.ConclusionMultiple susceptibility gene testing in PDAC patients with family history of pancreatic cancer is warranted regardless of FPC status and will inform genetic risk counseling for families.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Deleterious variants in the known pancreatic cancer susceptibility genes account for ~10–20% of the familial clustering of pancreatic cancer.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094
Syngal, S., Brand, R. E., Church, J. M., Giardiello, F. M., Hampel, H. L., & Burt, R. W. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.435 · Cited by 1,662
Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors
Tassan, N. A. A., Chmiel, N. H., Maynard, J. H., Fleming, N. I., Livingston, A. L., Williams, G. T., Hodges, A., Davies, D. R., David, S. S., Sampson, J. R., et al. (2002) · Nature Genetics · doi:10.1038/ng828 · Cited by 1,408
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
Jones, S., Hruban, R. H., Kamiyama, M., Borges, M., Zhang, X., Parsons, D. W., Lin, J. C.-H., Palmisano, E., Brune, K., Jaffee, E. M., et al. (2009) · Science · doi:10.1126/science.1171202 · Cited by 826 · cited 13×
“Twenty-seven individuals were found to carry a PV in a gene associated with increased risk of breast cancer (ATM, BARD1, BRCA1, BRCA2, CHEK2, PALB2, NBN).”
InfluentialLocalization of an ataxia-telangiectasia gene to chromosome 11q22–23
Gatti, R. A., Berkel, İ., Boder, E., Braedt, G., Charmley, P., CONCANNON, P. J., Ersoy, F., Foroud, T., Jaspers, N. G. J., Lange, K. L., et al. (1988) · Nature · doi:10.1038/336577a0 · Cited by 684
Genetic/Familial High-Risk Assessment: Breast and Ovarian
Daly, M. B., Axilbund, J. E., Buys, S. S., Crawford, B., Farrell, C. D., Friedman, S., Garber, J. E., Goorha, S., Gruber, S. B., Hampel, H., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0043 · Cited by 646
Tung, N., Lin, N., Kidd, J., Allen, B. A., Singh, N., WENSTRUP, R. J., Hartman, A., Winer, E. P., & Garber, J. E. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.0747 · Cited by 580
Self-citationCHEK2 Is a Multiorgan Cancer Susceptibility Gene
Cybulski, C., Górski, B., Huzarski, T., Masojć, B., Mierzejewski, M., Dębniak, T., Teodorczyk, U., Byrski, T., Gronwald, J., Matyjasik, J., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/426403 · Cited by 560
Risk of Pancreatic Cancer in Families With Lynch Syndrome
Kastrinos, F. (2009) · JAMA · doi:10.1001/jama.2009.1529 · Cited by 544
ATM Mutations in Patients with Hereditary Pancreatic Cancer
Roberts, N. J., Jiao, Y., Yu, J., Kopelovich, L., Petersen, G. M., Bondy, M. L., Gallinger, S., Schwartz, A. G., Syngal, S., Cote, M. L., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0194 · Cited by 491
Self-citation* (2004) · The American Journal of Human Genetics · doi:10.1086/421251 · Cited by 476
Vasen, H. F. A., Stormorken, A. T., Menko, F. H., Nagengast, F. M., Kleibeuker, J. H., Griffioen, G. G., Taal, B. G., Møller, P., & Wijnen, J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.20.4074 · Cited by 406
Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma
Holter, S., Borgida, A., Dodd, A., Grant, R., Semotiuk, K., Hedley, D., Dhani, N., Narod, S., Akbari, M., Moore, M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.7401 · Cited by 398
Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer
Roberts, N. J., Norris, A. L., Petersen, G. M., Bondy, M. L., Brand, R., Gallinger, S., Kurtz, R. C., Olson, S. H., Rustgi, A. K., Schwartz, A. G., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0402 · Cited by 361
Self-citationMutations in CHEK2 Associated with Prostate Cancer Risk
Dong, X., Wang, L., Taniguchi, K., Wang, X., Cunningham, J. M., McDonnell, S. K., Qian, C., Marks, A. F., Slager, S. L., Peterson, B. J., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/346094 · Cited by 313
Prevalence of Germline Mutations in Cancer Predisposition Genes in Patients With Pancreatic Cancer
Grant, R. C., Selander, I., Connor, A. A., Selvarajah, S., Borgida, A., Briollais, L., Petersen, G. M., Lerner-Ellis, J., Holter, S., & Gallinger, S. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.11.042 · Cited by 299
Self-citationBRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study
Zhen, D. B., Rabe, K. G., Gallinger, S., Syngal, S., Schwartz, A. G., Goggins, M. G., Hruban, R. H., Cote, M. L., McWilliams, R. R., Roberts, N. J., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2014.153 · Cited by 295
Self-citationZhang, B., Beeghly-Fadiel, A. C., Long, J., & Zheng, W. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70076-6 · Cited by 276
Yurgelun, M. B. B., Allen, B. A., Kaldate, R., Bowles, K. R., Judkins, T., Kaushik, P., Roa, B. B., WENSTRUP, R. J., Hartman, A., & Syngal, S. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.006 · Cited by 260
Self-citationProvenzale, D., Gupta, S. N., Ahnen, D. J., Bray, T., Cannon, J. A., Cooper, G. S., David, D. S., Early, D. S., Erwin, D. O., Ford, J. M., et al. (2016) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2016.0108 · Cited by 255
Genetic susceptibility to pancreatic cancer
Klein, A. P. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20855 · Cited by 240
Meijers-Heijboer, H. E. J., Wasielewski, M., Wagner, A., Hollestelle, A., Elstrodt, F., van den Bos, R. R., de Snoo, A., Fat, G. T. A., Brekelmans, C. T. M., Jagmohan, S., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375121 · Cited by 226
Hruban, R. H., Petersen, G. M., Ha, P. K., & Kern, S. E. (1998) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30282-5 · Cited by 194
Self-citationPancreatic carcinoma and hereditary nonpolyposis colorectal cancer: A family study
Lynch, H. T., Voorhees, G. J., Lanspa, S. J., McGreevy, P. S., & Lynch, J. F. (1985) · British Journal of Cancer · doi:10.1038/bjc.1985.187 · Cited by 191
Eggington, J. M., Bowles, K. R., Moyes, K., Manley, S., Esterling, L. E., Sizemore, S., Rosenthal, E., Theisen, A. P., Saam, J. R., Arnell, C., et al. (2013) · Clinical Genetics · doi:10.1111/cge.12315 · Cited by 188
Self-citationPancreatic Cancer Genetic Epidemiology Consortium
Petersen, G. M., de Andrade, M., Goggins, M., Hruban, R. H., Bondy, M. L., Korczak, J. F., Gallinger, S., Lynch, H. T., Syngal, S., Rabe, K. G., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0734 · Cited by 141
Self-citationPrevalence of pathogenic mutations in cancer predisposition genes among pancreatic cancer patients
Hu, C., Hart, S. N., Bamlet, W. R., Moore, R. M., Nandakumar, K., Eckloff, B. W., Lee, Y. K., Petersen, G. M., McWilliams, R. R., & Couch, F. J. (2016) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0455 · Cited by 137
Self-citationLin, K. M., Shashidharan, M., Thorson, A. G., Ternent, C. A., Blatchford, G. J., Christensen, M. A., Watson, P. A., Lemon, S. J., Franklin, B., Karr, B., et al. (1998) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(98)80105-4 · Cited by 137
Judkins, T., Leclair, B., Bowles, K., Gutin, N., Trost, J., McCulloch, J., Bhatnagar, S., Murray, A., Craft, J., Wardell, B., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1224-y · Cited by 118
Cancer Risk of Heterozygotes With the NBN Founder Mutation
Seemanová, E., Jarolı́m, P., Seeman, P., Varon, R., Digweed, M., Swift, M., & Sperling, K. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm251 · Cited by 96
Duodenal carcinoma in MUTYH-associated polyposis
Nielsen, M., Poley, J., Verhoef, S., van Puijenbroek, M., Weiss, M. M., Burger, G. T., Dommering, C. J., Vasen, H. F. A., Kuipers, E. J., Wagner, A., et al. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.031757 · Cited by 55
Smith, A. L., Alirezaie, N., Connor, A. A., Chan‐Seng‐Yue, M., Grant, R. C., Selander, I., Bascuñana, C., Borgida, A., Hall, A., Whelan, T., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.10.030 · Cited by 54
Self-citationFamilial pancreatic adenocarcinoma
Petersen, G. M. (2015) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.04.007 · Cited by 53
Self-citationBarnetson, R., Devlin, L., Miller, J. D., Farrington, S., Slater, S., DRAKE, A. C., Campbell, H., Dunlop, M. G., & Porteous, M. (2007) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00900.x · Cited by 49
Rosenthal, E. T., Evans, B. A., Kidd, J., Brown, K. L., Gorringe, H., van Orman, M., & Manley, S. (2016) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2016.10.003 · Cited by 30
Self-citationYang, X. R., Rotunno, M., Xiao, Y., Ingvar, C., Helgadóttir, H., Pastorino, L., van Doorn, R., Bennett, H. R., Graham, C., Sampson, J. N., et al. (2016) · Human Genetics · doi:10.1007/s00439-016-1715-1 · Cited by 27
van Marcke, C., Vikkula, M., & Duhoux, F. P. (2017) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2017.01.017 · Cited by 18
Flagged first, then by citations
Cited by
Sorted by citations
Daly, M. B., Pal, T., Berry, M. P., Buys, S. S., Dickson, P., Domchek, S. M., Elkhanany, A. M., Friedman, S., Goggins, M., Hutton, M. L., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0001 · Cited by 1,143
Goggins, M., Overbeek, K. A., Brand, R., Syngal, S., Del Chiaro, M., Bartsch, D. K., Bassi, C., Carrato, A., Farrell, J., Fishman, E. K., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319352 · Cited by 659
Hu, C., Hart, S. N., Polley, E. C., Gnanaolivu, R., Shimelis, H., Lee, K. Y., Lilyquist, J., Na, J., Moore, R., Antwi, S. O., et al. (2018) · JAMA · doi:10.1001/jama.2018.6228 · Cited by 577
Self-citationPancreatic cancer: A review of epidemiology, trend, and risk factors
Hu, J.-X., Zhao, C., Chen, W.-B., Liu, Q., Li, Q.-W., Lin, Y., & Gao, F. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i27.4298 · Cited by 643
Daly, M. B., Pilarski, R., Yurgelun, M. B. B., Berry, M. P., Buys, S. S., Dickson, P., Domchek, S. M., Elkhanany, A. M., Friedman, S., Garber, J. E., et al. (2020) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.0017 · Cited by 517
Metadata
- Authors
- Chaffee, K. G., Oberg, A. L., McWilliams, R. R., Majithia, N., Allen, B. A., Kidd, J., Singh, N., Hartman, A.-R., Wenstrup, R. J., & Petersen, G. M.
- Affiliations
- Mayo Clinic (US)
- Myriad Genetics (US)
- Corresponding author
- Petersen, Gloria M.
- ORCID
- Venue
- Genetics in Medicine
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 20
- Issue
- 1
- Pages
- 119-127
- ISSN
- 1098-3600 (ISSN-L)
- PMC
- PMC5760284
- OpenAlex
- W2738571634
- Cited by
- 144
- References
- 38
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 15 · 2023: 23 · 2022: 19 · 2021: 34 · 2020: 14 · 2019: 10 · 2018: 9
- FWCI
- 6.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Genetics in Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (CA102701)
- National Cancer Institute (CA102701, R01CA-97075, P50CA102701, R01CA097075)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- pancreatic ductal adenocarcinoma, germline mutations, cancer susceptibility genes, familial pancreatic cancer, family history (medicine), mutation prevalence, BRCA2, ATM, CDKN2A, CHEK2, MUTYH, BARD1, PMS2, novel mutations
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alleles, Carcinoma, Female, Genetic Testing, Genotype, Humans, Male, Middle Aged, Pancreatic Neoplasms, Registries, United States, Prevalence, Germ-Line Mutation, Genetic Predisposition to Disease, High-Throughput Nucleotide Sequencing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
